Table 2.
Evolution of ulcer areas and local adverse events during follow-up of PG and HC participants
Variables | PG (n=9)* | HC (n=12)* | p-value | Total |
---|---|---|---|---|
Ulcer area (cm2)-median(p25-p75) | ||||
D0 | 7.4(5.5-10.3) | 16.1(6.2-47.9) | <0.01 | 10.3(5.8-18.0) |
D90 | 2.7(1.5-3.7) | 4.9(2.3-21.3) | 3.2(1.5-21.3) | |
Adverseevent-N(%) | ||||
Criticalcolonization | 4(44) | 2(17) | 0.33 | 6(29) |
Increased area | 3(33) | 1(8) | 0.27 | 4(19) |
PG - Platelet gel; HC - Hydrocolloid.